N. Wurtz, M.P. Grobusch, D. Raoult Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room B.A. Cunha Clinical Microbiology and Infection

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Malaria in Europe: emerging threat or minor nuisance?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain A. Doménech-Sánchez Clinical Microbiology.

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

An eye-catching acanthocephalan

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Results from a mathematical model for human monocytic ehrlichiosis

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

CMI editorial report 2013 Clinical Microbiology and Infection

Bioterrorism: myth or reality?

Training for the infectious diseases speciality in Norway

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever? S. Edouard, A. Michel-Lepage, D. Raoult

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Clinical microbiologists facing an anthrax alert

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

Rickettsia felis and Rickettsia massiliae in Ivory Coast, Africa

The practice of travel medicine in Europe

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Vaccinations against respiratory tract infections at Hajj

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Real-time comparative monitoring of the A/H1N1 pandemic in France

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment J.C. Clegg Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

C. Socolovschi, D. Raoult, P. Parola

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Negative impact of laws regarding biosecurity and bioterrorism on real diseases N. Wurtz, M.P. Grobusch, D. Raoult Clinical Microbiology and Infection Volume 20, Issue 6, Pages 507-515 (June 2014) DOI: 10.1111/1469-0691.12709 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Published items collected from the Institute for Scientific Information Web of Knowledge (blue curve), and numbers of websites (found by a Google search) containing the words ‘bioterrorism’ (red curve), ‘anthrax’ (green curve) and ‘smallpox’ (purple curve) in the world between 1995 and 2013. Clinical Microbiology and Infection 2014 20, 507-515DOI: (10.1111/1469-0691.12709) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Cumulative analysis of items published on bacterial biological select agents and toxins in each year, (a) Global analysis in the world, (b) Global analysis in France, (c) Global analysis in URMITE laboratory. Clinical Microbiology and Infection 2014 20, 507-515DOI: (10.1111/1469-0691.12709) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions